
CWBR
Healthcare · Biotechnology · $1.2M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Mar 31, 2023
EPS trend, 90 days to now · +100.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 14, 2023 | After the close | — | -1.49 | — |
| May 15, 2023 | Before the open | -0.60 | -0.75 | -24.2% |
| Mar 9, 2023 | After the close | -0.90 | -1.30 | -44.4% |
| Nov 8, 2022 | After the close | -1.02 | -0.82 | +19.6% |
| Aug 15, 2022 | After the close | -1.20 | -0.90 | +25.0% |
| May 16, 2022 | After the close | -1.35 | -1.20 | +11.1% |
| Mar 29, 2022 | After the close | -1.65 | -1.20 | +27.3% |
| Nov 15, 2021 | After the close | -2.20 | -1.50 | +31.8% |
| Aug 10, 2021 | After the close | -1.80 | -2.40 | -33.3% |
| May 17, 2021 | After the close | -2.10 | -2.10 | 0.0% |
| Mar 30, 2021 | After the close | -1.86 | -2.40 | -29.0% |
| Nov 16, 2020 | After the close | -2.10 | -1.80 | +14.3% |
| Aug 13, 2020 | After the close | -0.06 | -0.09 |
CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases.…
| -50.0% |
| May 14, 2020 | After the close | — | -0.10 | — |
| Mar 12, 2020 | After the close | — | -0.09 | — |
| Nov 6, 2019 | After the close | — | -0.08 | — |
| Aug 7, 2019 | After the close | — | -0.07 | — |
| May 7, 2019 | After the close | — | -0.07 | — |
| Mar 18, 2019 | Time not confirmed | — | -0.10 | — |
| Nov 14, 2018 | Time not confirmed | — | -0.11 | — |
| Aug 14, 2018 | Time not confirmed | — | -0.08 | — |
| Apr 2, 2018 | Time not confirmed | — | -0.07 | — |